48 studies found for:    Open Studies | "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
21 Recruiting A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
22 Recruiting Extension Study Evaluating the Safety and Efficacy of Subcutaneous RoActemra/Actemra Administration in Patients With Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra]
23 Recruiting A Study of Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
24 Recruiting A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Golimumab;   Drug: Methotrexate
25 Recruiting Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis
Condition: Juvenile Idiopathic Arthritis Associated Uveitis
Intervention: Drug: Tocilizumab
26 Recruiting Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Abatacept
27 Recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis, Rheumatoid Arthritis
Intervention: Drug: Tocilizumab [RoActemra/Actemra]
28 Recruiting a Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis Who Participated in the Study CACZ885G2301E1
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: canakinumab
29 Recruiting Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
Condition: Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
Intervention: Biological: Abatacept
30 Unknown  Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: intra-articular steroid injection
31 Not yet recruiting "Medikidz Explain JIA Comic Book- Hebrew"
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: reading comics booklet
32 Not yet recruiting Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
Condition: Juvenile Idiopathic Arthritis
33 Not yet recruiting Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Biological: Canakinumab
34 Not yet recruiting ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
Condition: Systemic Juvenile Idiopathic Arthritis (SJIA)
Intervention: Drug: ACZ885 150 mg (Canakinumab)
35 Not yet recruiting Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: Controlled physical activity
36 Not yet recruiting Biomarkers in Saliva in Children With Juvenil Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
37 Not yet recruiting A Peer E-mentoring Intervention to Improve Employment
Conditions: Cerebral Palsy;   Spina Bifida;   Juvenile Arthritis;   Spinal Cord Injury;   Muscular Dystrophy;   Physical Disability
Intervention: Behavioral: Empowering youth towards employment
38 Not yet recruiting Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
Conditions: Osteoporosis;   Juvenile Rheumatoid Arthritis;   Dermatomyositis;   Polyarthritis;   Systemic Lupus Erythematosis;   Vasculitis;   Glucocorticoid-induced Osteoporosis
Intervention: Drug: denosumab
39 Unknown  Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
Conditions: Chronic Hepatitis B;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis;   Juvenile Idiopathic Arthritis
Interventions: Drug: Entecavir;   Drug: Placebo
40 Unknown  Use of Thermal and 3D Imaging to Quantify Arthritis
Conditions: Rheumatoid Arthritis;   Juvenile Rheumatoid Arthritis
Intervention: Other: 3D and thermal imaging

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-48) Show next page of results    Last Page
Indicates status has not been verified in more than two years